# Study to Assess Safety and Efficacy of Fingolimod in Children With Rett Syndrome

> **NCT02061137** · PHASE1,PHASE2 · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 6 (actual)

## Conditions studied

- Rett's Syndrome

## Interventions

- **DRUG:** fingolimod (FTY720)

## Key facts

- **NCT ID:** NCT02061137
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2018-04
- **Final completion:** 2018-04
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2018-06-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02061137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02061137, "Study to Assess Safety and Efficacy of Fingolimod in Children With Rett Syndrome". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02061137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*